奧扎格雷鈉聯(lián)合降纖酶應(yīng)用于腦血栓治療的臨床療效觀察

打開(kāi)文本圖片集

【摘要】目的：探討奧扎格雷鈉聯(lián)合降纖酶應(yīng)用于腦血栓治療的臨床療效。方法：從我院擇選腦血栓患者60例，時(shí)間線(xiàn)2019年1月—2021年1月，分為采取單純的奧扎格雷鈉治療（對(duì)照組）與采取奧扎格雷鈉聯(lián)合降纖酶治療（觀察組），兩組均為30例。比較兩組效果。結(jié)果：觀察組總有效率高于對(duì)照組（P

【關(guān)鍵詞】奧扎格雷鈉；降纖酶；腦血栓；生活質(zhì)量；并發(fā)癥

Clinical observation of ozagrel sodium combined with defibrase in the treatment of cerebral thrombosis

YU Miaomiao

Bohai new area people’s hospital， Cangzhou， Hebei 061113， China

【Abstract 】Objective：To investigate the clinical efficacy of ozagrel sodium combined with defibrase in the treatment of cerebral thrombosis.Methods：60 patients with cerebral thrombosis were selected from our hospital from January 2019 to January 2021.The patients were divided into simple ozagrel sodium treatment （control group） and ozagrel sodium combined withdefibrasetreatment （observation group），there were 30 cases in each group.The effects of the two groups were compared.Results The total effective rate in the observation group was higher than that in the control group（P

【Key Words】Ozagrel sodium； Defibrase； Cerebral thrombosis； Quality of life； Complication

腦血栓是當(dāng)前臨床非常常見(jiàn)的一種腦血管疾病，主要高發(fā)于中老年人群，該病具有發(fā)病急、發(fā)病率高、高死亡率的特點(diǎn)。（剩余3312字）